 Home > Medical News > Latest Medical News > Lunan Pharmaceutical ``Axitinib'' was approved for listing

Lunan Pharmaceutical ``Axitinib'' was approved for listing

 Last Update: 2021-06-01
 Source: Internet
 Author: User

Tags

buy 2 4

letrozole breast cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Pharmaceutical Guanlan

On May 25th, Lunan Pharmaceutical issued a press release stating that axitinib tablets developed by Shandong New Times Pharmaceuticals under its subsidiary have been approved by the National Medical Products Administration (NMPA) for use in a tyrosine kinase that has previously been received.

Axitinib is a small molecule tyrosine kinase inhibitor (TKI).

It is worth mentioning that the National Comprehensive Cancer Network (NCCN), European Society of Urology (EAU), Chinese Society of Clinical Oncology (CSCO) and many other authoritative kidney cancer diagnosis and treatment guidelines at home and abroad have recommended axitinib as: advanced stage Second-line treatment of renal clear cell carcinoma after the failure of first-line molecular targeted drug therapy.

Renal cell carcinoma is the most common kidney cancer, accounting for 90% of the total number of kidney cancers.

According to the NMPA official website, only Pfizer's axitinib was approved for listing in China before.

Reference materials:

[1] The first imitation of Lunan Pharmaceutical's axitinib tablet was approved! Retrieved May 25, 2021, from https://mp.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.